| Mr Matthew Thomas Economy, MSPT | |
|
27 Cross St, Belfast, ME 04915-6356 | |
| (207) 338-3955 | |
| (207) 338-2642 |
| Full Name | Mr Matthew Thomas Economy |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 19 Years |
| Location | 27 Cross St, Belfast, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548238652 | NPI | - | NPPES |
| P00456591 | Other | MEDICARE RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT4183 (Maine) | Primary |
| 225100000X | Physical Therapist | PT0000007385 (Tennessee) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greater Brunswick Physical Therapy Pa | 8426019621 | 13 |
News Archive
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
New insight into the function of a gene important in the suppression of cancer is published today. Researchers at the National University of Ireland Galway have shown that the TP53 gene has even greater anti-cancer activity than previously thought.
Regenstrief Institute investigator Shaun Grannis M.D., M.S., associate professor of family medicine at the Indiana University School of Medicine, has been inducted as a fellow of the American College of Medical Informatics. He joins a select elected group of individuals who have made significant and sustained contributions to the field of biomedical informatics.
"Europe is becoming a 'hotspot' for emerging infections as those typically confined to tropical climates are making their way north, according to research that links climate change to the global spread of disease," the Financial Times reports.
An opinion paper by researchers from the US and Italy recently discussed various aspects of monitoring anti-SARS-CoV-2 antibodies before and after receiving COVID-19 vaccination to highlight the pros and cons of this monitoring strategy. This paper is published in the open-access journal Diagnostics.
› Verified 7 days ago
| Provider Name | Greater Brunswick Physical Therapy Pa |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1568567659 PECOS PAC ID: 8426019621 Enrollment ID: O20041021000255 |
News Archive
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
New insight into the function of a gene important in the suppression of cancer is published today. Researchers at the National University of Ireland Galway have shown that the TP53 gene has even greater anti-cancer activity than previously thought.
Regenstrief Institute investigator Shaun Grannis M.D., M.S., associate professor of family medicine at the Indiana University School of Medicine, has been inducted as a fellow of the American College of Medical Informatics. He joins a select elected group of individuals who have made significant and sustained contributions to the field of biomedical informatics.
"Europe is becoming a 'hotspot' for emerging infections as those typically confined to tropical climates are making their way north, according to research that links climate change to the global spread of disease," the Financial Times reports.
An opinion paper by researchers from the US and Italy recently discussed various aspects of monitoring anti-SARS-CoV-2 antibodies before and after receiving COVID-19 vaccination to highlight the pros and cons of this monitoring strategy. This paper is published in the open-access journal Diagnostics.
› Verified 7 days ago
| Provider Name | Therapy Partners Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1598170987 PECOS PAC ID: 1658591912 Enrollment ID: O20141008001793 |
News Archive
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
New insight into the function of a gene important in the suppression of cancer is published today. Researchers at the National University of Ireland Galway have shown that the TP53 gene has even greater anti-cancer activity than previously thought.
Regenstrief Institute investigator Shaun Grannis M.D., M.S., associate professor of family medicine at the Indiana University School of Medicine, has been inducted as a fellow of the American College of Medical Informatics. He joins a select elected group of individuals who have made significant and sustained contributions to the field of biomedical informatics.
"Europe is becoming a 'hotspot' for emerging infections as those typically confined to tropical climates are making their way north, according to research that links climate change to the global spread of disease," the Financial Times reports.
An opinion paper by researchers from the US and Italy recently discussed various aspects of monitoring anti-SARS-CoV-2 antibodies before and after receiving COVID-19 vaccination to highlight the pros and cons of this monitoring strategy. This paper is published in the open-access journal Diagnostics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Matthew Thomas Economy, MSPT Po Box 423, Winterport, ME 04496-0423 Ph: (678) 849-6426 | Mr Matthew Thomas Economy, MSPT 27 Cross St, Belfast, ME 04915-6356 Ph: (207) 338-3955 |
News Archive
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.
New insight into the function of a gene important in the suppression of cancer is published today. Researchers at the National University of Ireland Galway have shown that the TP53 gene has even greater anti-cancer activity than previously thought.
Regenstrief Institute investigator Shaun Grannis M.D., M.S., associate professor of family medicine at the Indiana University School of Medicine, has been inducted as a fellow of the American College of Medical Informatics. He joins a select elected group of individuals who have made significant and sustained contributions to the field of biomedical informatics.
"Europe is becoming a 'hotspot' for emerging infections as those typically confined to tropical climates are making their way north, according to research that links climate change to the global spread of disease," the Financial Times reports.
An opinion paper by researchers from the US and Italy recently discussed various aspects of monitoring anti-SARS-CoV-2 antibodies before and after receiving COVID-19 vaccination to highlight the pros and cons of this monitoring strategy. This paper is published in the open-access journal Diagnostics.
› Verified 7 days ago
Lillian Redwine, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-505-4832 | |
Kaly Rumery, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 118 Northport Ave, Belfast, ME 04915 Phone: 207-505-4186 | |
Adam Sitarski, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2 Footbridge Rd, Belfast, ME 04915 Phone: 207-338-5307 Fax: 207-930-7041 | |
Bart A Hotchkin, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 53 Schoodic Dr, Belfast, ME 04915 Phone: 207-338-6900 Fax: 207-338-6944 | |
Heather Marie Hessler, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Parkside Ln, Belfast, ME 04915 Phone: 207-218-2001 | |
Elizabeth V Durham, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 1 Parkside Ln, Belfast, ME 04915 Phone: 207-323-1021 | |
Steven James Hoffman, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Spring St., Belfast, ME 04915 Phone: 207-323-4452 |